Filing
Spy
Filing
Spy
Home
About
ZNTL
Zentalis Pharmaceuticals Inc
Clinical-stage biopharmaceutical company
CUSIP: 98943L107
Healthcare
US
1 holder
Ownership
Activity
Fundamentals
2021 Q3
4 of 9 quarters
Total Value
$141.16M
Total Shares
2.12M
Net Share Change
-281.0K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Viking Global Investors
$141.16M
2.12M
0.4%
TRIM
-281.0K
(-11.7%)
Viking Global Investors
$141.16M
2.12M shares
TRIM
-281.0K
(-11.7%)
ZNTL — Zentalis Pharmaceuticals Inc - FilingSpy